These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9463520)

  • 1. Deprotonation and hydride shifts in nitrenium and iminium forms of aminoimidazole-azaarene mutagens.
    Colvin ME; Seidl ET; Nielsen IM; Le Bui L; Hatch FT
    Chem Biol Interact; 1997 Dec; 108(1-2):39-66. PubMed ID: 9463520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and quantum chemical factors affecting mutagenic potency of aminoimidazo-azaarenes.
    Hatch FT; Colvin ME; Seidl ET
    Environ Mol Mutagen; 1996; 27(4):314-30. PubMed ID: 8665874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic nitrenes/nitrenium ions from azido-imidazoarenes and their structure-activity relationships.
    Wild D; Dirr A
    Mutagenesis; 1989 Nov; 4(6):446-52. PubMed ID: 2695757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and decomposition of an ester derivative of the procarcinogen and promutagen, PhIP, 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine: unusual nitrenium ion chemistry.
    Nguyen TM; Novak M
    J Org Chem; 2007 Jun; 72(13):4698-706. PubMed ID: 17542636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity (QSAR) relationships of mutagenic aromatic and heterocyclic amines.
    Hatch FT; Colvin ME
    Mutat Res; 1997 May; 376(1-2):87-96. PubMed ID: 9202742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of the carcinogenic/mutagenic potential of arylamines to their singlet-triplet nitrenium ion energies.
    Hartman GD; Schlegel HB
    Chem Biol Interact; 1981 Sep; 36(3):319-30. PubMed ID: 7285238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships of mutagenic aromatic and heteroaromatic azides and amines.
    Sabbioni G; Wild D
    Carcinogenesis; 1992 Apr; 13(4):709-13. PubMed ID: 1576721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic potential of nitrenium ions of nitrobenzanthrones: correlation between theory and experiment.
    Reynisson J; Stiborová M; Martínek V; Gamboa da Costa G; Phillips DH; Arlt VM
    Environ Mol Mutagen; 2008 Oct; 49(8):659-67. PubMed ID: 18618595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel pathway to the ultimate mutagens of aromatic amino and nitro compounds.
    Wild D
    Environ Health Perspect; 1990 Aug; 88():27-31. PubMed ID: 2272323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultimate carcinogenic metabolites from aromatic and heterocyclic aromatic amines: a computational study in relation to their mutagenic potency.
    Borosky GL
    Chem Res Toxicol; 2007 Feb; 20(2):171-80. PubMed ID: 17261035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling via nitrenium ion chemistry: protonation of the nitrene derived from 4-amino-3-nitrophenyl azide to afford reactive nitrenium ion pairs.
    Voskresenska V; Wilson RM; Panov M; Tarnovsky AN; Krause JA; Vyas S; Winter AH; Hadad CM
    J Am Chem Soc; 2009 Aug; 131(32):11535-47. PubMed ID: 19624129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical and biological factors affecting mutagen potency.
    Colvin ME; Hatch FT; Felton JS
    Mutat Res; 1998 May; 400(1-2):479-92. PubMed ID: 9685706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency.
    Hatch FT; Knize MG; Colvin ME
    Environ Mol Mutagen; 2001; 38(4):268-91. PubMed ID: 11774358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoidance of the Ames test liability for aryl-amines via computation.
    McCarren P; Bebernitz GR; Gedeck P; Glowienke S; Grondine MS; Kirman LC; Klickstein J; Schuster HF; Whitehead L
    Bioorg Med Chem; 2011 May; 19(10):3173-82. PubMed ID: 21524589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum-chemical studies on mutagenicity of aromatic and heteroaromatic amines.
    Borosky GL
    Front Biosci (Schol Ed); 2013 Jan; 5(2):600-10. PubMed ID: 23277072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of crystal structure and theory for 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Parkin S; Marsch GA; Hope H; Whitney E; Winter NW; Colvin ME; Felton JS; Turteltaub KW
    Chem Res Toxicol; 1996; 9(3):574-9. PubMed ID: 8728500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituent effects on electrophilic catalysis by the carbonyl group: anatomy of the rate acceleration for PLP-catalyzed deprotonation of glycine.
    Crugeiras J; Rios A; Riveiros E; Richard JP
    J Am Chem Soc; 2011 Mar; 133(9):3173-83. PubMed ID: 21323335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of calculated electronic parameters of fifteen aniline derivatives with their mutagenic potencies.
    Loew GH; Sudhindra BS; Walker JM; Sigman CC; Johnson HL
    J Environ Pathol Toxicol; 1979; 2(4):1069-78. PubMed ID: 448254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocyclic amine formation and the impact of structure on their mutagenicity.
    Felton JS; Knize MG; Hatch FT; Tanga MJ; Colvin ME
    Cancer Lett; 1999 Sep; 143(2):127-34. PubMed ID: 10503891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the forces of stabilizing complexes between chlorophylls and heterocyclic amine mutagens.
    Dashwood R; Yamane S; Larsen R
    Environ Mol Mutagen; 1996; 27(3):211-8. PubMed ID: 8625957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.